Genome editing in drug discovery:
GENOME EDITING IN DRUG DISCOVERYA practical guide for researchers and professionals applying genome editing techniques to drug discoveryIn Genome Editing in Drug Discovery, a team of distinguished biologists delivers a comprehensive exploration of genome editing in the drug discovery process, with c...
Gespeichert in:
Weitere Verfasser: | , |
---|---|
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
Hoboken, NJ
Wiley
2022
|
Schlagworte: | |
Online-Zugang: | UBR01 Volltext |
Zusammenfassung: | GENOME EDITING IN DRUG DISCOVERYA practical guide for researchers and professionals applying genome editing techniques to drug discoveryIn Genome Editing in Drug Discovery, a team of distinguished biologists delivers a comprehensive exploration of genome editing in the drug discovery process, with coverage of the technology's history, current issues and techniques, and future perspectives and research directions. The book discusses techniques for disease modeling, target identification with CRISPR, safety studies, therapeutic editing, and intellectual property issues.The safety and efficacy of drugs and new target discovery, as well as next-generation therapeutics are also presented.Offering practical suggestions for practitioners and academicians involved in drug discovery, Genome Editing in Drug Discovery is a fulsome treatment of a technology that has become part of nearly every early step in the drug discovery pipeline. Selected contributions also include:* A thorough introduction to the applications of CRISPRi and CRISPRa in drug discovery* Comprehensive explorations of genome-editing applications in stem cell engineering and regenerative medicine* Practical discussions of the safety aspects of genome editing with respect to immunogenicity and the specificity of CRISPR-Cas9 gene editing* In-depth examinations of critical socio-economic and bioethical challenges in the CRISPR-Cas9 patent landscapePerfect for academic researchers and professionals in the biotech and pharmaceutical industries, Genome Editing in Drug Discovery will also earn a place in the libraries of medicinal chemists, biochemists, and molecular biologists |
Beschreibung: | Prelim pages; Contents; Preface ((to follow)); 1. Genome editing in drug discovery; 2. Historical overview of Genome Editing from bacteria to higher eukaryotes; 3. CRISPR Cas: from bacterial adaptive immunity to the swiss army knife of drug discovery; 4. Commercial reagents and services for genome editing; 5. Computational tools for target design and analysis; 6. Genome editing in cellular disease models; 7. Utilizing CRISPR/Cas9 technologies for in vivo disease modeling and therapy; 8. Pooled CRISPR KO screens for target identification; 9. Functional genomics: arrayed CRISPR KO screens; 10. Applications of CRISPRi and CRISPRa in drug discovery; 11. High throughput targeted mutagenesis by CRISPR-Cas9 base editing; 12. Single-cell transcriptomics and epigenomics for CRISPR-mediated perturbation studies; 13. DNA repair pathways in the context of therapeutic genome editing; 14. DNA base editing strategies for genome editing; 15. RNA base editing technologies for gene therapy; 16. Genome Editing applications in cancer T Cell Therapy; 17. Genome-editing applications in stem cell engineering and regenerative medicine; 18. Delivery and Formulation Methods for Therapeutic Genome Editing; 19. Safety aspects of genome editing: Immunogenicity; 20. Specificity of CRISPR-Cas9 gene editing; 21. Key socio-economic and (bio)ethical challenges in the crispr-cas9 patent landscape; 22. Future prospects and emerging technologies for genome editing; Subject Index |
Beschreibung: | 1 Online-Ressource (x, 342 Seiten) Illustrationen, Diagramme |
ISBN: | 9781119671404 |
Internformat
MARC
LEADER | 00000nmm a2200000 c 4500 | ||
---|---|---|---|
001 | BV049091937 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | cr|uuu---uuuuu | ||
008 | 230807s2022 |||| o||u| ||||||eng d | ||
020 | |a 9781119671404 |9 978-1-119-67140-4 | ||
024 | 7 | |a 10.1002/9781119671404 |2 doi | |
035 | |a (OCoLC)1401187287 | ||
035 | |a (DE-599)BVBBV049091937 | ||
040 | |a DE-604 |b ger |e rda | ||
041 | 0 | |a eng | |
049 | |a DE-355 | ||
084 | |a VS 5350 |0 (DE-625)147687:253 |2 rvk | ||
245 | 1 | 0 | |a Genome editing in drug discovery |c edited by Marcello Maresca, Sumit Deswal |
264 | 1 | |a Hoboken, NJ |b Wiley |c 2022 | |
300 | |a 1 Online-Ressource (x, 342 Seiten) |b Illustrationen, Diagramme | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
500 | |a Prelim pages; Contents; Preface ((to follow)); 1. Genome editing in drug discovery; 2. Historical overview of Genome Editing from bacteria to higher eukaryotes; 3. CRISPR Cas: from bacterial adaptive immunity to the swiss army knife of drug discovery; 4. Commercial reagents and services for genome editing; 5. Computational tools for target design and analysis; 6. Genome editing in cellular disease models; 7. Utilizing CRISPR/Cas9 technologies for in vivo disease modeling and therapy; 8. Pooled CRISPR KO screens for target identification; 9. Functional genomics: arrayed CRISPR KO screens; 10. Applications of CRISPRi and CRISPRa in drug discovery; 11. High throughput targeted mutagenesis by CRISPR-Cas9 base editing; 12. Single-cell transcriptomics and epigenomics for CRISPR-mediated perturbation studies; 13. DNA repair pathways in the context of therapeutic genome editing; 14. DNA base editing strategies for genome editing; 15. RNA base editing technologies for gene therapy; 16. Genome Editing applications in cancer T Cell Therapy; 17. Genome-editing applications in stem cell engineering and regenerative medicine; 18. Delivery and Formulation Methods for Therapeutic Genome Editing; 19. Safety aspects of genome editing: Immunogenicity; 20. Specificity of CRISPR-Cas9 gene editing; 21. Key socio-economic and (bio)ethical challenges in the crispr-cas9 patent landscape; 22. Future prospects and emerging technologies for genome editing; Subject Index | ||
520 | |a GENOME EDITING IN DRUG DISCOVERYA practical guide for researchers and professionals applying genome editing techniques to drug discoveryIn Genome Editing in Drug Discovery, a team of distinguished biologists delivers a comprehensive exploration of genome editing in the drug discovery process, with coverage of the technology's history, current issues and techniques, and future perspectives and research directions. The book discusses techniques for disease modeling, target identification with CRISPR, safety studies, therapeutic editing, and intellectual property issues.The safety and efficacy of drugs and new target discovery, as well as next-generation therapeutics are also presented.Offering practical suggestions for practitioners and academicians involved in drug discovery, Genome Editing in Drug Discovery is a fulsome treatment of a technology that has become part of nearly every early step in the drug discovery pipeline. Selected contributions also include:* A thorough introduction to the applications of CRISPRi and CRISPRa in drug discovery* Comprehensive explorations of genome-editing applications in stem cell engineering and regenerative medicine* Practical discussions of the safety aspects of genome editing with respect to immunogenicity and the specificity of CRISPR-Cas9 gene editing* In-depth examinations of critical socio-economic and bioethical challenges in the CRISPR-Cas9 patent landscapePerfect for academic researchers and professionals in the biotech and pharmaceutical industries, Genome Editing in Drug Discovery will also earn a place in the libraries of medicinal chemists, biochemists, and molecular biologists | ||
650 | 0 | 7 | |a Genome Editing |0 (DE-588)1116095971 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a CRISPR/Cas-Methode |0 (DE-588)1116100770 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Arzneimittelforschung |0 (DE-588)4003120-2 |2 gnd |9 rswk-swf |
653 | |a Chemie | ||
655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
689 | 0 | 0 | |a Genome Editing |0 (DE-588)1116095971 |D s |
689 | 0 | 1 | |a Arzneimittelforschung |0 (DE-588)4003120-2 |D s |
689 | 0 | 2 | |a CRISPR/Cas-Methode |0 (DE-588)1116100770 |D s |
689 | 0 | |5 DE-604 | |
700 | 1 | |a Maresca, Marcello |0 (DE-588)1256969656 |4 edt | |
700 | 1 | |a Deswal, Sumit |d 1983- |0 (DE-588)1021538698 |4 edt | |
776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe, PDF |z 978-1-119-67138-1 |
776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe, EPUB |z 978-1-119-67139-8 |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 978-1-119-67134-3 |
856 | 4 | 0 | |u https://onlinelibrary.wiley.com/doi/book/10.1002/9781119671404 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
912 | |a ZDB-35-UBC | ||
999 | |a oai:aleph.bib-bvb.de:BVB01-034353646 | ||
966 | e | |u https://onlinelibrary.wiley.com/doi/book/10.1002/9781119671404 |l UBR01 |p ZDB-35-UBC |q UBR EBS Auswahl 2022 |x Verlag |3 Volltext |
Datensatz im Suchindex
_version_ | 1804185429331673088 |
---|---|
adam_txt | |
any_adam_object | |
any_adam_object_boolean | |
author2 | Maresca, Marcello Deswal, Sumit 1983- |
author2_role | edt edt |
author2_variant | m m mm s d sd |
author_GND | (DE-588)1256969656 (DE-588)1021538698 |
author_facet | Maresca, Marcello Deswal, Sumit 1983- |
building | Verbundindex |
bvnumber | BV049091937 |
classification_rvk | VS 5350 |
collection | ZDB-35-UBC |
ctrlnum | (OCoLC)1401187287 (DE-599)BVBBV049091937 |
discipline | Chemie / Pharmazie |
discipline_str_mv | Chemie / Pharmazie |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>05100nmm a2200493 c 4500</leader><controlfield tag="001">BV049091937</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">230807s2022 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781119671404</subfield><subfield code="9">978-1-119-67140-4</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1002/9781119671404</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1401187287</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV049091937</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VS 5350</subfield><subfield code="0">(DE-625)147687:253</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Genome editing in drug discovery</subfield><subfield code="c">edited by Marcello Maresca, Sumit Deswal</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Hoboken, NJ</subfield><subfield code="b">Wiley</subfield><subfield code="c">2022</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (x, 342 Seiten)</subfield><subfield code="b">Illustrationen, Diagramme</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Prelim pages; Contents; Preface ((to follow)); 1. Genome editing in drug discovery; 2. Historical overview of Genome Editing from bacteria to higher eukaryotes; 3. CRISPR Cas: from bacterial adaptive immunity to the swiss army knife of drug discovery; 4. Commercial reagents and services for genome editing; 5. Computational tools for target design and analysis; 6. Genome editing in cellular disease models; 7. Utilizing CRISPR/Cas9 technologies for in vivo disease modeling and therapy; 8. Pooled CRISPR KO screens for target identification; 9. Functional genomics: arrayed CRISPR KO screens; 10. Applications of CRISPRi and CRISPRa in drug discovery; 11. High throughput targeted mutagenesis by CRISPR-Cas9 base editing; 12. Single-cell transcriptomics and epigenomics for CRISPR-mediated perturbation studies; 13. DNA repair pathways in the context of therapeutic genome editing; 14. DNA base editing strategies for genome editing; 15. RNA base editing technologies for gene therapy; 16. Genome Editing applications in cancer T Cell Therapy; 17. Genome-editing applications in stem cell engineering and regenerative medicine; 18. Delivery and Formulation Methods for Therapeutic Genome Editing; 19. Safety aspects of genome editing: Immunogenicity; 20. Specificity of CRISPR-Cas9 gene editing; 21. Key socio-economic and (bio)ethical challenges in the crispr-cas9 patent landscape; 22. Future prospects and emerging technologies for genome editing; Subject Index</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">GENOME EDITING IN DRUG DISCOVERYA practical guide for researchers and professionals applying genome editing techniques to drug discoveryIn Genome Editing in Drug Discovery, a team of distinguished biologists delivers a comprehensive exploration of genome editing in the drug discovery process, with coverage of the technology's history, current issues and techniques, and future perspectives and research directions. The book discusses techniques for disease modeling, target identification with CRISPR, safety studies, therapeutic editing, and intellectual property issues.The safety and efficacy of drugs and new target discovery, as well as next-generation therapeutics are also presented.Offering practical suggestions for practitioners and academicians involved in drug discovery, Genome Editing in Drug Discovery is a fulsome treatment of a technology that has become part of nearly every early step in the drug discovery pipeline. Selected contributions also include:* A thorough introduction to the applications of CRISPRi and CRISPRa in drug discovery* Comprehensive explorations of genome-editing applications in stem cell engineering and regenerative medicine* Practical discussions of the safety aspects of genome editing with respect to immunogenicity and the specificity of CRISPR-Cas9 gene editing* In-depth examinations of critical socio-economic and bioethical challenges in the CRISPR-Cas9 patent landscapePerfect for academic researchers and professionals in the biotech and pharmaceutical industries, Genome Editing in Drug Discovery will also earn a place in the libraries of medicinal chemists, biochemists, and molecular biologists</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Genome Editing</subfield><subfield code="0">(DE-588)1116095971</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">CRISPR/Cas-Methode</subfield><subfield code="0">(DE-588)1116100770</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelforschung</subfield><subfield code="0">(DE-588)4003120-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Chemie</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Genome Editing</subfield><subfield code="0">(DE-588)1116095971</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Arzneimittelforschung</subfield><subfield code="0">(DE-588)4003120-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">CRISPR/Cas-Methode</subfield><subfield code="0">(DE-588)1116100770</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Maresca, Marcello</subfield><subfield code="0">(DE-588)1256969656</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Deswal, Sumit</subfield><subfield code="d">1983-</subfield><subfield code="0">(DE-588)1021538698</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Online-Ausgabe, PDF</subfield><subfield code="z">978-1-119-67138-1</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Online-Ausgabe, EPUB</subfield><subfield code="z">978-1-119-67139-8</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">978-1-119-67134-3</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://onlinelibrary.wiley.com/doi/book/10.1002/9781119671404</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-35-UBC</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-034353646</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://onlinelibrary.wiley.com/doi/book/10.1002/9781119671404</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-35-UBC</subfield><subfield code="q">UBR EBS Auswahl 2022</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
genre_facet | Aufsatzsammlung |
id | DE-604.BV049091937 |
illustrated | Not Illustrated |
index_date | 2024-07-03T22:30:07Z |
indexdate | 2024-07-10T09:55:05Z |
institution | BVB |
isbn | 9781119671404 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-034353646 |
oclc_num | 1401187287 |
open_access_boolean | |
owner | DE-355 DE-BY-UBR |
owner_facet | DE-355 DE-BY-UBR |
physical | 1 Online-Ressource (x, 342 Seiten) Illustrationen, Diagramme |
psigel | ZDB-35-UBC ZDB-35-UBC UBR EBS Auswahl 2022 |
publishDate | 2022 |
publishDateSearch | 2022 |
publishDateSort | 2022 |
publisher | Wiley |
record_format | marc |
spelling | Genome editing in drug discovery edited by Marcello Maresca, Sumit Deswal Hoboken, NJ Wiley 2022 1 Online-Ressource (x, 342 Seiten) Illustrationen, Diagramme txt rdacontent c rdamedia cr rdacarrier Prelim pages; Contents; Preface ((to follow)); 1. Genome editing in drug discovery; 2. Historical overview of Genome Editing from bacteria to higher eukaryotes; 3. CRISPR Cas: from bacterial adaptive immunity to the swiss army knife of drug discovery; 4. Commercial reagents and services for genome editing; 5. Computational tools for target design and analysis; 6. Genome editing in cellular disease models; 7. Utilizing CRISPR/Cas9 technologies for in vivo disease modeling and therapy; 8. Pooled CRISPR KO screens for target identification; 9. Functional genomics: arrayed CRISPR KO screens; 10. Applications of CRISPRi and CRISPRa in drug discovery; 11. High throughput targeted mutagenesis by CRISPR-Cas9 base editing; 12. Single-cell transcriptomics and epigenomics for CRISPR-mediated perturbation studies; 13. DNA repair pathways in the context of therapeutic genome editing; 14. DNA base editing strategies for genome editing; 15. RNA base editing technologies for gene therapy; 16. Genome Editing applications in cancer T Cell Therapy; 17. Genome-editing applications in stem cell engineering and regenerative medicine; 18. Delivery and Formulation Methods for Therapeutic Genome Editing; 19. Safety aspects of genome editing: Immunogenicity; 20. Specificity of CRISPR-Cas9 gene editing; 21. Key socio-economic and (bio)ethical challenges in the crispr-cas9 patent landscape; 22. Future prospects and emerging technologies for genome editing; Subject Index GENOME EDITING IN DRUG DISCOVERYA practical guide for researchers and professionals applying genome editing techniques to drug discoveryIn Genome Editing in Drug Discovery, a team of distinguished biologists delivers a comprehensive exploration of genome editing in the drug discovery process, with coverage of the technology's history, current issues and techniques, and future perspectives and research directions. The book discusses techniques for disease modeling, target identification with CRISPR, safety studies, therapeutic editing, and intellectual property issues.The safety and efficacy of drugs and new target discovery, as well as next-generation therapeutics are also presented.Offering practical suggestions for practitioners and academicians involved in drug discovery, Genome Editing in Drug Discovery is a fulsome treatment of a technology that has become part of nearly every early step in the drug discovery pipeline. Selected contributions also include:* A thorough introduction to the applications of CRISPRi and CRISPRa in drug discovery* Comprehensive explorations of genome-editing applications in stem cell engineering and regenerative medicine* Practical discussions of the safety aspects of genome editing with respect to immunogenicity and the specificity of CRISPR-Cas9 gene editing* In-depth examinations of critical socio-economic and bioethical challenges in the CRISPR-Cas9 patent landscapePerfect for academic researchers and professionals in the biotech and pharmaceutical industries, Genome Editing in Drug Discovery will also earn a place in the libraries of medicinal chemists, biochemists, and molecular biologists Genome Editing (DE-588)1116095971 gnd rswk-swf CRISPR/Cas-Methode (DE-588)1116100770 gnd rswk-swf Arzneimittelforschung (DE-588)4003120-2 gnd rswk-swf Chemie (DE-588)4143413-4 Aufsatzsammlung gnd-content Genome Editing (DE-588)1116095971 s Arzneimittelforschung (DE-588)4003120-2 s CRISPR/Cas-Methode (DE-588)1116100770 s DE-604 Maresca, Marcello (DE-588)1256969656 edt Deswal, Sumit 1983- (DE-588)1021538698 edt Erscheint auch als Online-Ausgabe, PDF 978-1-119-67138-1 Erscheint auch als Online-Ausgabe, EPUB 978-1-119-67139-8 Erscheint auch als Druck-Ausgabe 978-1-119-67134-3 https://onlinelibrary.wiley.com/doi/book/10.1002/9781119671404 Verlag URL des Erstveröffentlichers Volltext |
spellingShingle | Genome editing in drug discovery Genome Editing (DE-588)1116095971 gnd CRISPR/Cas-Methode (DE-588)1116100770 gnd Arzneimittelforschung (DE-588)4003120-2 gnd |
subject_GND | (DE-588)1116095971 (DE-588)1116100770 (DE-588)4003120-2 (DE-588)4143413-4 |
title | Genome editing in drug discovery |
title_auth | Genome editing in drug discovery |
title_exact_search | Genome editing in drug discovery |
title_exact_search_txtP | Genome editing in drug discovery |
title_full | Genome editing in drug discovery edited by Marcello Maresca, Sumit Deswal |
title_fullStr | Genome editing in drug discovery edited by Marcello Maresca, Sumit Deswal |
title_full_unstemmed | Genome editing in drug discovery edited by Marcello Maresca, Sumit Deswal |
title_short | Genome editing in drug discovery |
title_sort | genome editing in drug discovery |
topic | Genome Editing (DE-588)1116095971 gnd CRISPR/Cas-Methode (DE-588)1116100770 gnd Arzneimittelforschung (DE-588)4003120-2 gnd |
topic_facet | Genome Editing CRISPR/Cas-Methode Arzneimittelforschung Aufsatzsammlung |
url | https://onlinelibrary.wiley.com/doi/book/10.1002/9781119671404 |
work_keys_str_mv | AT marescamarcello genomeeditingindrugdiscovery AT deswalsumit genomeeditingindrugdiscovery |